
Alopecia Management in Primary Care: Expert Insights from ACP 2025
William Lewis, MD, discussed the importance of photo-documentation, referral indicators, efficacy of various treatments, and other topics.
At the American College of Physicians Internal Medicine Meeting 2025, April 3-5, 2025, in New Orleans, 
Dr Lewis opened his presentation by underscoring the fact that 
Key Insights on Management:
- Assessment Protocol: Physicians were encouraged to ask targeted questions during patient evaluations regarding the specific nature of hair loss. And Dr Lewis noted that distinguishing between shedding and thinning is crucial for diagnosis as shedding often indicates telogen effluvium, while thinning suggests different underlying causes. Physicians should also ask whether hair loss is symptomatic as itching or pain suggests an inflammatory process.
 - Take Pictures: 
Alopecia treatments may work slowly, so patients may not notice even an excellent treatment response. Dr Lewis stressed that taking pictures can serve as a powerful tool in reassuring patients and encouraging them to adhere to treatment protocols. A study of standardized scalp photography in 119 people seen for follow-up at a hair specialty clinic showed that 98.3% of participants reported they were more motivated to continue treatment after seeing images, and 52.9% rated alopecia as less severe after seeing images.1 - Referral Indicators: Identifying red flags such as atypical patterns of hair loss, active inflammation, or noticeable post-inflammatory changes is vital for determining when to refer patients to dermatological specialists.
 - Effective Counseling: Dr Lewis urged physicians to educate patients on the causes and triggers of hair loss, establishing realistic expectations surrounding treatment timelines and outcomes.
 
Treatment Modalities
Dr Lewis also discussed both FDA-approved and off-label treatment options, with topical minoxidil and oral finasteride being highlighted for androgenetic alopecia. He also covered emerging nonpharmaceutical treatments, such as low-level light therapy and platelet-rich plasma injections, which are gaining traction as viable options for hair regrowth. In discussing laboratory testing, physicians were advised to consider a panel of evaluations, including iron studies, vitamin D levels, TSH, and hormonal assessments in patients demonstrating virilizing signs, particularly in women.
References:
1. Pathoulas JT, Flanagan KE, Walker CJ, et al. Evaluation of standardized scalp photography on patient perception of hair loss severity, anxiety, and treatment. J Am Acad Dermatol. 2021;85:1640-1641. doi:10.1016/j.jaad.2020.12.059
Newsletter
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.

































































































































































































































































































